Oscar Health Reports Q3 2026 Profitability and Raises Full-Year Revenue and Earnings Guidance
Oscar Health (OSCR) reported a significant financial turnaround in the third quarter of 2026, posting a net income of $167.3 million ($0.49 per diluted share) compared to a loss in the prior year period. The company's revenue surged 70% year-over-year to $5.1 billion, fueled by higher membership levels and rate increases. Key operational improvements included a Medical Loss Ratio (MLR) of 84.0% and a record-low SG&A expense ratio of 14.0%, driven largely by AI efficiencies and fixed cost leverage. Following these strong results, management raised its full-year 2026 outlook for both revenue ($19.0B–$19.3B) and earnings from operations ($850M–$950M). While the company lowered its risk adjustment guidance due to year-to-date experience, it remains focused on long-term growth with a 2029 EPS target of at least $4.00 and a planned 14% rate increase for 2027 to combat rising medical costs.
Tickers: $OSCR
Topics: guidance upgrade membership increase net income improvement revenue growth